Preprint · CC-BY
via OpenAlex
Natural Product-Derived Acyl-Tryptamine Conjugates: A Systematic Series of Sixty-Nine Novel Dual-Release Prodrug Candidates Targeting Neuroinflammation, Senescence, Neuroprotection, and Serotonergic Modulation
ChemRxiv · 2026
Deregulated nutrient-sensing
Mitochondrial dysfunction
Cellular senescence
Chronic inflammation
Senolytics
Abstract
A novel series of sixty-nine N-acyl tryptamine conjugates is presented, organised into twentythree structural classes derived from natural product scaffolds: ergolin-8-oyl, berberin-9-oyl, resveratrol-3-oyl, pterostilben-3-oyl, hesperetin-2-oyl, naringenin-2-oyl, eriodictyol-2-oyl, taxifolin-2-oyl, quercetin-2-oyl, isorhamnetin-2-oyl, tamarixetin-2-oyl, rhamnetin-2-oyl, fisetin-2-oyl, kaempferol-2-oyl, galangin-2-oyl, apigenin-2-oyl, luteolin-2-oyl, diosmetin-2-oyl, baicalein-2-oyl, wogonin-2-oyl, chrysin-2-oyl, curcumin-4-oyl, and silibinin-oyl. All compounds share a secondary amide bond linking the acyl moiety to substituted tryptamine scaffolds bearing 4-hydroxy, 5-methoxy, or 4-acetoxy substitution, with enzymatic hydrolysis proposed to simultaneously release a pharmacologically active tryptamine and a bioactive natural product-derived acyl fragment. The twenty-three classes introduce mechanistically distinct secondary hypotheses including SIRT1/AMPK activation, Nrf2 induction, AhR modulation, NF-κB inhibition, MAO-B inhibition, senolytic activity, D2 receptor modulation, aromatase inhibition, and mitochondrial redox support. All sixty-nine compounds are new chemical entities; no synthesis or biological testing has been performed. SMILES strings, predicted physicochemical properties, and hypothetical pharmacological profiles are provided to stimulate further investigation. This series constitutes the fourth instalment of a systematic acyl-tryptamine prodrug platform, complementing three preceding publications describing heteroaromatic, endogenous, and phytochemical acyl classes across fifty-five additional compounds.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.26434/chemrxiv.15000712/v1
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Kisourin, S. (2026). Natural Product-Derived Acyl-Tryptamine Conjugates: A Systematic Series of Sixty-Nine Novel Dual-Release Prodrug Candidates Targeting Neuroinflammation, Senescence, Neuroprotection, and Serotonergic Modulation. <em>ChemRxiv</em>. https://doi.org/10.26434/chemrxiv.15000712/v1
Vancouver
Kisourin S. Natural Product-Derived Acyl-Tryptamine Conjugates: A Systematic Series of Sixty-Nine Novel Dual-Release Prodrug Candidates Targeting Neuroinflammation, Senescence, Neuroprotection, and Serotonergic Modulation. ChemRxiv. 2026. doi:10.26434/chemrxiv.15000712/v1.
BibTeX
@unpublished{stanley2026Natura,
title = {Natural Product-Derived Acyl-Tryptamine Conjugates: A Systematic Series of Sixty-Nine Novel Dual-Release Prodrug Candidates Targeting Neuroinflammation, Senescence, Neuroprotection, and Serotonergic Modulation},
author = {Stanley Kisourin},
journal = {ChemRxiv},
year = {2026},
doi = {10.26434/chemrxiv.15000712/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Inflammopharmacology 2017
Open access · CC-BY
Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling
Biomolecules 2021
Open access · CC-BY
Chemoinformatic Screening for the Selection of Potential Senolytic Compounds from Natural Products
Experimental Gerontology 2025
Open access · CC-BY
Association between body roundness index with femoral neck bone mineral density, osteoporosis, and FRAX score in middle-aged and older adults: A cross-sectional study
Benha Medical Journal 2020
Open access · OA
Resveratrol and/or Metformin Activates Serum Sirtuin-1 and Decreases Insulin Resistance in High Fructose-Fed Rats
Cells 2024
Open access · CC-BY
Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD+) by Synergistic Inhibition of CD38 Expression
Aging cell 2026
Open access · OA